Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471282) titled 'Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy' on March 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Chuansheng Zhao
Condition:
Stroke
Intervention:
Drug: Tenecteplase (0.0938mg/kg)
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: March 1, 2026
Target Sample Size: 344
Countries of Recruitment:
China
To know more, visit https...